vs
Side-by-side financial comparison of Sight Sciences, Inc. (SGHT) and Spok Holdings, Inc (SPOK). Click either name above to swap in a different company.
Spok Holdings, Inc is the larger business by last-quarter revenue ($33.9M vs $20.4M, roughly 1.7× Sight Sciences, Inc.). Spok Holdings, Inc runs the higher net margin — 8.7% vs -20.4%, a 29.1% gap on every dollar of revenue. On growth, Sight Sciences, Inc. posted the faster year-over-year revenue change (6.9% vs -0.1%). Spok Holdings, Inc produced more free cash flow last quarter ($10.1M vs $-2.0M). Over the past eight quarters, Sight Sciences, Inc.'s revenue compounded faster (2.9% CAGR vs -1.5%).
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
Spok Holdings, Inc. is a global provider of critical communication solutions primarily serving the healthcare industry. It offers unified clinical communication platforms, secure messaging tools, alerting systems, and on-call scheduling software that help care teams coordinate efficiently, cut response times, and boost patient safety across medical facilities.
SGHT vs SPOK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.4M | $33.9M |
| Net Profit | $-4.2M | $2.9M |
| Gross Margin | 87.3% | 76.7% |
| Operating Margin | -18.0% | 11.6% |
| Net Margin | -20.4% | 8.7% |
| Revenue YoY | 6.9% | -0.1% |
| Net Profit YoY | 64.9% | -19.6% |
| EPS (diluted) | $-0.07 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.4M | $33.9M | ||
| Q3 25 | $19.9M | $33.9M | ||
| Q2 25 | $19.6M | $35.7M | ||
| Q1 25 | $17.5M | $36.3M | ||
| Q4 24 | $19.1M | $33.9M | ||
| Q3 24 | $20.2M | $34.9M | ||
| Q2 24 | $21.4M | $34.0M | ||
| Q1 24 | $19.3M | $34.9M |
| Q4 25 | $-4.2M | $2.9M | ||
| Q3 25 | $-8.2M | $3.2M | ||
| Q2 25 | $-11.9M | $4.6M | ||
| Q1 25 | $-14.2M | $5.2M | ||
| Q4 24 | $-11.8M | $3.6M | ||
| Q3 24 | $-11.1M | $3.7M | ||
| Q2 24 | $-12.3M | $3.4M | ||
| Q1 24 | $-16.3M | $4.2M |
| Q4 25 | 87.3% | 76.7% | ||
| Q3 25 | 86.4% | 78.3% | ||
| Q2 25 | 84.8% | 79.5% | ||
| Q1 25 | 86.2% | 80.1% | ||
| Q4 24 | 86.8% | 78.5% | ||
| Q3 24 | 83.9% | 79.5% | ||
| Q2 24 | 85.8% | 78.9% | ||
| Q1 24 | 85.5% | 79.5% |
| Q4 25 | -18.0% | 11.6% | ||
| Q3 25 | -39.7% | 12.9% | ||
| Q2 25 | -59.6% | 15.1% | ||
| Q1 25 | -79.2% | 16.6% | ||
| Q4 24 | -62.5% | 13.7% | ||
| Q3 24 | -55.7% | 14.2% | ||
| Q2 24 | -59.2% | 13.2% | ||
| Q1 24 | -76.4% | 14.0% |
| Q4 25 | -20.4% | 8.7% | ||
| Q3 25 | -41.0% | 9.5% | ||
| Q2 25 | -61.0% | 12.8% | ||
| Q1 25 | -80.8% | 14.3% | ||
| Q4 24 | -62.1% | 10.8% | ||
| Q3 24 | -54.9% | 10.5% | ||
| Q2 24 | -57.7% | 10.1% | ||
| Q1 24 | -84.4% | 12.1% |
| Q4 25 | $-0.07 | $0.13 | ||
| Q3 25 | $-0.16 | $0.15 | ||
| Q2 25 | $-0.23 | $0.22 | ||
| Q1 25 | $-0.28 | $0.25 | ||
| Q4 24 | $-0.23 | $0.17 | ||
| Q3 24 | $-0.22 | $0.18 | ||
| Q2 24 | $-0.25 | $0.17 | ||
| Q1 24 | $-0.33 | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $92.0M | $25.3M |
| Total DebtLower is stronger | $42.4M | — |
| Stockholders' EquityBook value | $63.9M | $146.4M |
| Total Assets | $115.3M | $206.1M |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $92.0M | $25.3M | ||
| Q3 25 | $92.4M | $21.4M | ||
| Q2 25 | $101.5M | $20.2M | ||
| Q1 25 | $108.8M | $19.9M | ||
| Q4 24 | $120.4M | $29.1M | ||
| Q3 24 | $118.6M | $27.8M | ||
| Q2 24 | $118.2M | $23.9M | ||
| Q1 24 | $127.3M | $23.3M |
| Q4 25 | $42.4M | — | ||
| Q3 25 | $42.4M | — | ||
| Q2 25 | $42.4M | — | ||
| Q1 25 | $42.4M | — | ||
| Q4 24 | $40.0M | — | ||
| Q3 24 | $37.1M | — | ||
| Q2 24 | $35.0M | — | ||
| Q1 24 | $35.0M | — |
| Q4 25 | $63.9M | $146.4M | ||
| Q3 25 | $64.3M | $148.7M | ||
| Q2 25 | $70.0M | $150.9M | ||
| Q1 25 | $77.6M | $151.7M | ||
| Q4 24 | $87.5M | $154.7M | ||
| Q3 24 | $95.0M | $156.3M | ||
| Q2 24 | $101.6M | $158.2M | ||
| Q1 24 | $109.2M | $160.2M |
| Q4 25 | $115.3M | $206.1M | ||
| Q3 25 | $116.3M | $209.7M | ||
| Q2 25 | $122.0M | $208.7M | ||
| Q1 25 | $129.7M | $204.5M | ||
| Q4 24 | $142.8M | $217.1M | ||
| Q3 24 | $143.6M | $216.8M | ||
| Q2 24 | $149.7M | $216.4M | ||
| Q1 24 | $155.6M | $215.0M |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.66× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | 0.46× | — | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 0.32× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.8M | $11.5M |
| Free Cash FlowOCF − Capex | $-2.0M | $10.1M |
| FCF MarginFCF / Revenue | -9.7% | 29.9% |
| Capex IntensityCapex / Revenue | 0.8% | 4.1% |
| Cash ConversionOCF / Net Profit | — | 3.93× |
| TTM Free Cash FlowTrailing 4 quarters | — | $25.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.8M | $11.5M | ||
| Q3 25 | $-8.7M | $8.1M | ||
| Q2 25 | $-7.5M | $7.0M | ||
| Q1 25 | $-11.6M | $2.3M | ||
| Q4 24 | $-3.5M | $8.4M | ||
| Q3 24 | $362.0K | $11.1M | ||
| Q2 24 | $-9.5M | $7.4M | ||
| Q1 24 | $-9.8M | $2.0M |
| Q4 25 | $-2.0M | $10.1M | ||
| Q3 25 | $-8.9M | $7.6M | ||
| Q2 25 | $-7.8M | $6.0M | ||
| Q1 25 | — | $1.5M | ||
| Q4 24 | $-3.6M | $7.5M | ||
| Q3 24 | $311.0K | $10.3M | ||
| Q2 24 | $-9.5M | $6.8M | ||
| Q1 24 | $-9.9M | $1.1M |
| Q4 25 | -9.7% | 29.9% | ||
| Q3 25 | -44.7% | 22.4% | ||
| Q2 25 | -39.6% | 16.8% | ||
| Q1 25 | — | 4.2% | ||
| Q4 24 | -18.9% | 22.3% | ||
| Q3 24 | 1.5% | 29.4% | ||
| Q2 24 | -44.7% | 20.0% | ||
| Q1 24 | -51.4% | 3.2% |
| Q4 25 | 0.8% | 4.1% | ||
| Q3 25 | 0.9% | 1.6% | ||
| Q2 25 | 1.1% | 2.9% | ||
| Q1 25 | 0.0% | 2.1% | ||
| Q4 24 | 0.7% | 2.5% | ||
| Q3 24 | 0.3% | 2.4% | ||
| Q2 24 | 0.4% | 1.9% | ||
| Q1 24 | 0.6% | 2.5% |
| Q4 25 | — | 3.93× | ||
| Q3 25 | — | 2.54× | ||
| Q2 25 | — | 1.55× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | — | 2.31× | ||
| Q3 24 | — | 3.03× | ||
| Q2 24 | — | 2.17× | ||
| Q1 24 | — | 0.47× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
SPOK
| Paging | $16.8M | 50% |
| Software Operations | $16.0M | 47% |
| License | $1.2M | 4% |
